ArticleResearch square2023

Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease.

Mitzi M Gonzales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.